Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences International Conference on Advances in Next Generation Sequencing

Amit Dutt's Biography

Amit Dutt, Principal Investigator, Scientist F, Tata Memorial Centre

Dr Amit Dutt is a Principal Investigator (Scientist F) at ACTREC, Tata Memorial Centre. He is a recipient of two Ph.D degrees. After completing his doctoral studies in Plant Genetics from ICGEB, he pursued second Ph.D in Developmental Biology from the Univ. of Zurich, Switzerland; is a recipient of the Swiss National Science Foundation post-doctoral fellowship award (2005); the Ramalingaswami Fellowship Award (2010) and the Wellcome Trust/ DBT India Alliance Intermediate Fellowship (2012). He is a Faculty Member in Medical Genetics- F1000 Prime; serves on the Editorial Board of PLOS ONE; BMC Genomics; and, on the advisory Board of several start up companies in India. Before joining ACTREC, Dr. Dutt completed his postdoctoral studies at the Broad Institute of MIT and Harvard. He has published in several reputed scientific journals including Nature, Nature Genetics, Cancer Discovery, PNAS, Cancer Research, Anals of Oncology, British Journal of Cancer, Chem Biol, etc….

Amit Dutt Image

Translating Cancer Genomics to Medicine

Friday, 29 May 2015 at 12:25

Add to Calendar ▼2015-05-28 00:00:002015-05-28 01:00:00Europe/LondonTranslating Cancer Genomics to MedicineInternational Conference on Advances in Next Generation Sequencing in

This talk will highlight newer generation SNP arrays and massively parallel Next Generation DNA sequencing technologies for complete genome characterization of Cancer will helps in advancing Cancer Sciences and leading to discovery of novel molecular subclasses, new therapeutic targets and biomarkers for clinical development. In addition, this talk will discuss  how by using these and conventional technologies will help to the identification of causal alterations in human cancer and discovery of  novel somatic activating alterations at FGFR2, EGFR, AKT, PDGFRA and FGFR1 mutations in endometrial cancer, lung squamous carcinoma and cervical carcinoma. Finally, it will discuss the recent advances in discovery and characterization of  some novel potentially therapeutic target in Indian samples of lung carcinomas and head and neck cancer.

Add to Calendar ▼2015-05-28 00:00:002015-05-29 00:00:00Europe/LondonInternational Conference on Advances in Next Generation SequencingInternational Conference on Advances in Next Generation Sequencing in